Biotron completes clinical stage of HIV clinical trial 28 April 201314 December 2012 by Karen Mobbs Biotron completes clinical stage of HIV clinical trial
Results of Annual General Meeting 28 April 201328 November 2012 by Karen Mobbs Results of Annual General Meeting
Presentation to Annual General Meeting 28 February 201428 November 2012 by Justine Bednorz Presentation to Annual General Meeting
Commencement of three-month toxicology studies for BIT225 28 April 201327 November 2012 by Karen Mobbs Commencement of three-month toxicology studies for BIT225
Key Phase 2 HIV/HCV trial commenced 28 April 20139 November 2012 by Karen Mobbs Key Phase 2 HIV/HCV trial commenced
Presentation to investors 28 February 201426 October 2012 by Justine Bednorz Presentation to investors
Annual Report for year ended 30 June 2012 and Notice of Annual General Meeting 28 April 201325 October 2012 by Karen Mobbs Annual Report for year ended 30 June 2012 and Notice of Annual General Meeting
Quarterly Report 30 September 2012 28 April 201323 October 2012 by Karen Mobbs Quarterly Report 30 September 2012
Biotron Limited to report new clinical data from BIT225 Hepatitis C Phase 2a trial in a late-breaking presentation at the AASLD 2012 annual conference 28 April 201316 October 2012 by Karen Mobbs Biotron Limited to report new clinical data from BIT225 Hepatitis C Phase 2a trial in a late-breaking presentation at the AASLD 2012 annual conference
October edition of BITNews 28 April 201311 October 2012 by Karen Mobbs October 2012 edition of BITNews
